Keap1/Nrf2/ARE signaling unfolds therapeutic targets for redox imbalanced-mediated diseases and diabetic nephropathy

被引：100

作者：

Adelusi, Temitope Isaac ^{[1
]}

Du, Lei ^{[1
]}

Hao, Meng ^{[1
]}

Zhou, Xueyan ^{[1
]}

Xuan, Qian ^{[1
]}

Apu, Chowdhury ^{[1
]}

Sun, Ying ^{[1
]}

Lu, Qian ^{[1
]}

Yin, Xiaoxing ^{[1
]}

机构：

[1] Xuzhou Med Univ, Jiangsu Key Lab New Drug Res & Clin Pharm, Xuzhou 221004, Jiangsu, Peoples R China

来源：

BIOMEDICINE & PHARMACOTHERAPY | 2020年 / 123卷

基金：

中国国家自然科学基金;

关键词：

Diabetic nephropathy; Keap1/Nrf2/ARE signaling; Oxidative stress; Antioxidant agents; Diabetic nephropathy biomarkers; GLYCATION END-PRODUCTS; RENIN-ANGIOTENSIN SYSTEM; NF-KAPPA-B; TRANSCRIPTION FACTOR NRF2; CONVERTING ENZYME-INHIBITORS; NEUTRALIZING RAGE-ANTIBODY; GLOMERULAR-FILTRATION-RATE; SUBSTRATE ADAPTER PROTEIN; CUL3-BASED E3 LIGASE; TISSUE GROWTH-FACTOR;

D O I：

10.1016/j.biopha.2019.109732

中图分类号：

R-3 [医学研究方法]; R3 [基础医学];

学科分类号：

1001 ;

摘要：

Hyperglycemia/oxidative stress has been implicated in the initiation and progression of diabetic complications while the components of Keap1/Nrf2/ARE signaling are being exploited as therapeutic targets for the treatment/management of these pathologies. Antioxidant agents like drugs, nutraceuticals and pure compounds that target the proteins of this pathway and their downstream genes hold the therapeutic strength to put the progression of this disease at bay. Here, we elucidate how the modulation of Keap1/Nrf2/ARE had been exploited for the treatment/management of end-stage diabetic kidney complication (diabetic nephropathy) by looking into (1) Nrf2 nuclear translocation and phosphorylation by some protein kinases at specific amino acid sequences and (2) Keap1 downregulation/Keap1-Nrf2 protein-protein inhibition (PPI) as potential therapeutic mechanisms exploited by Nrf2 activators for the modulation of diabetic nephropathy biomarkers (Collagen IV, Laminin, TGF-beta-1 and Fibronectin) that ultimately lead to the amelioration of this disease progression. Furthermore, we brought to limelight the relationship between diabetic nephropathy and Keap1/Nrf2/ARE and finally elucidate how the modulation of this signaling pathway could be further explored to create novel therapeutic milestones.

引用

收藏

页数：20

相关论文

共 233 条

[31] The Keap1-BTB protein is an adaptor that bridges Nrf2 to a Cul3-based E3 ligase: Oxidative stress sensing by a Cul3-Keap1 ligase [J].

Cullinan, SB ;

Gordan, JD ;

Jin, JO ;

Harper, JW ;

Diehl, JA .

MOLECULAR AND CELLULAR BIOLOGY, 2004, 24 (19) :8477-8486

[32] Bardoxolone Methyl in Type 2 Diabetes and Stage 4 Chronic Kidney Disease [J].

de Zeeuw, Dick ;

Akizawa, Tadao ;

Audhya, Paul ;

Bakris, George L. ;

Chin, Melanie ;

Christ-Schmidt, Heidi ;

Goldsberry, Angie ;

Houser, Mark ;

Krauth, Melissa ;

Heerspink, Hiddo J. Lambers ;

McMurray, John J. ;

Meyer, Colin J. ;

Parving, Hans-Henrik ;

Remuzzi, Giuseppe ;

Toto, Robert D. ;

Vaziri, Nosratola D. ;

Wanner, Christoph ;

Wittes, Janet ;

Wrolstad, Danielle ;

Chertow, Glenn M. .

NEW ENGLAND JOURNAL OF MEDICINE, 2013, 369 (26) :2492-2503

[33] Bach1 competes with Nrf2 leading to negative regulation of the antioxidant response element (ARE)-mediated NAD(P)H:quinone oxidoreductase 1 gene expression and induction in response to antioxidants [J].

Dhakshinamoorthy, S ;

Jain, AK ;

Bloom, DA ;

Jaiswal, AK .

JOURNAL OF BIOLOGICAL CHEMISTRY, 2005, 280 (17) :16891-16900

[34] Xanthohumol isolated from Humulus lupulus inhibits menadione-induced DNA damage through induction of quinone reductase [J].

Dietz, BM ;

Kang, YH ;

Liu, GW ;

Eggler, AL ;

Yao, P ;

Chadwick, LR ;

Pauli, GF ;

Farnsworth, NR ;

Mesecar, AD ;

van Breemen, RB ;

Bolton, JL .

CHEMICAL RESEARCH IN TOXICOLOGY, 2005, 18 (08) :1296-1305

[35] The synthetic triterpenoid, RTA 405, increases the glomerular filtration rate and reduces angiotensin II-induced contraction of glomerular mesangial cells [J].

Ding, Yanfeng ;

Stidham, Rhesa D. ;

Bumeister, Ron ;

Trevino, Isaac ;

Winters, Ali ;

Sprouse, Marc ;

Ding, Min ;

Ferguson, Deborah A. ;

Meyer, Colin J. ;

Wigley, W. Christian ;

Ma, Rong .

KIDNEY INTERNATIONAL, 2013, 83 (05) :845-854

[36] Keap1, the cysteine-based mammalian intracellular sensor for electrophiles and oxidants [J].

Dinkova-Kostova, Albena T. ;

Kostov, Rumen V. ;

Canning, Peter .

ARCHIVES OF BIOCHEMISTRY AND BIOPHYSICS, 2017, 617 :84-93

[37] Direct evidence that sulfhydryl groups of Keap1 are the sensors regulating induction of phase 2 enzymes that protect against carcinogens and oxidants [J].

Dinkova-Kostova, AT ;

Holtzclaw, WD ;

Cole, RN ;

Itoh, K ;

Wakabayashi, N ;

Katoh, Y ;

Yamamoto, M ;

Talalay, P .

PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2002, 99 (18) :11908-11913

[38] The role of Keap1 in cellular protective responses [J].

Dinkova-Kostova, AT ;

Holtzclaw, WD ;

Kensler, TW .

CHEMICAL RESEARCH IN TOXICOLOGY, 2005, 18 (12) :1779-1791

[39] Extremely potent triterpenoid inducers of the phase 2 response: Correlations of protection against oxidant and inflammatory stress [J].

Dinkova-Kostova, AT ;

Liby, KT ;

Stephenson, KK ;

Holtzclaw, WD ;

Gao, XQ ;

Suh, N ;

Williarrli, C ;

Risingsong, R ;

Honda, T ;

Gribble, GW ;

Sporn, MB ;

Talalay, P .

PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2005, 102 (12) :4584-4589

[40] Sodium butyrate activates NRF2 to ameliorate diabetic nephropathy possibly via inhibition of HDAC [J].

Dong, Wenpeng ;

Jia, Ye ;

Liu, Xiuxia ;

Zhang, Huan ;

Li, Tie ;

Huang, Wenlin ;

Chen, Xudong ;

Wang, Fuchun ;

Sun, Weixia ;

Wu, Hao .

JOURNAL OF ENDOCRINOLOGY, 2017, 232 (01) :71-83

← 1 2 3 4 5 6 7 8 9 10 →